Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fluorescent 4-Nitrobenzo-2-oxa-1,3-diazole-Coupled Bile Acids as Probe Substrates of Hepatic and Intestinal Bile Acid Transporters of the Solute Carrier Families SLC10 and SLCO. | J Med Chem | 2025 | 40380953 | PubTator, text mining | PubMed |
| Transfection of unmodified oligodeoxynucleotide with polyethylenimine reduces the level of hepatitis B surface antigen. | Front Microbiol | 2025 | 40376456 | PubTator, text mining | PubMed |
| HBV-induced N6 methyladenosine modification of PARP1 enhanced AFB1-related DNA damage and synergistically contribute to HCC. | Ecotoxicol Environ Saf | 2025 | 40344782 | PubTator, text mining | PubMed |
| Rapavir, a novel inhibitor of sodium taurocholate cotransporting polypeptide, potently blocks hepatitis B virus entry. | Signal Transduct Target Ther | 2025 | 40263266 | PubTator, text mining | PubMed |
| β-Sitosterol protects against lithocholic acid-induced hepatotoxicity and cholestasis via farnesoid X receptor-mediated regulation of transporters and enzymes in vitro and in vivo. | Toxicol Appl Pharmacol | 2025 | 40120651 | PubTator, text mining | PubMed |
| Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions. | Precis Clin Med | 2025 | 40110576 | PubTator, text mining | PubMed |
| Identification of NTCP animal orthologs supporting hepatitis B virus binding and infection. | J Virol | 2025 | 40042307 | PubTator, text mining | PubMed |
| SLC22A1 Resists Hepatitis B Virus by Activating the JAK/STAT Pathway and Predicts the Effect of Pegylated Interferon α-Based Therapy on Chronic Hepatitis B. | J Infect Dis | 2025 | 40036258 | PubTator, text mining | PubMed |
| Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug-Drug Interactions. | Pharmaceutics | 2025 | 40006617 | PubTator, text mining | PubMed |
| A Multivalent mRNA Therapeutic Vaccine Exhibits Breakthroughs in Immune Tolerance and Virological Suppression of HBV by Stably Presenting the Pre-S Antigen on the Cell Membrane. | Pharmaceutics | 2025 | 40006578 | PubTator, text mining | PubMed |
| Analysis of the Functional Role of TIMM29 in the Hepatitis B Virus Life Cycle. | Microbiol Immunol | 2025 | 39956808 | PubTator, text mining | PubMed |
| β-sitosterol protects against ANIT-induced hepatotoxicity and cholestasis via FXR activation. | Toxicol In Vitro | 2025 | 39947414 | PubTator, text mining | PubMed |
| Sodium taurocholate co-transporting polypeptide deficiency attenuates acetaminophen-induced hepatotoxicity via regulating expression of drug metabolism enzymes in mice. | Toxicol Appl Pharmacol | 2025 | 39947258 | PubTator, text mining | PubMed |
| Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes. | Proc Natl Acad Sci U S A | 2025 | 39937851 | PubTator, text mining | PubMed |
| Ellagic acid mitigates alpha-naphthyl isothiocyanate-induced cholestasis in rats via FXR activation and inflammatory pathway modulation. | J Complement Integr Med | 2025 | 39924693 | PubTator, text mining | PubMed |
| Endothelial lipase-binding peptides similar to netrin-1 inhibit hepatitis B virus infection. | FEBS Lett | 2025 | 39865491 | PubTator, text mining | PubMed |
| Identification of glycogen synthase kinase 3alpha/beta as a host factor required for HBV transcription using high-throughput screening. | Hepatology | 2025 | 39847392 | PubTator, text mining | PubMed |
| Manganese is a potent inducer of lysosomal activity that inhibits de novo HBV infection. | PLoS Pathog | 2025 | 39746094 | PubTator, text mining | PubMed |
| Discovery of pentacyclic triterpene conjugates as HBV polymerase/NTCP dual-targeting inhibitors with potent anti-HBV activities. | Bioorg Chem | 2025 | 39700828 | PubTator, text mining | PubMed |
| Hepatitis B and D virus entry. | Nat Rev Microbiol | 2025 | 39572840 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=7